𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Primary adrenal de novo CD5-positive diffuse large B cell lymphoma

✍ Scribed by Armin Rashidi, Catherine W. Bergeron, Stephen I. Fisher…

Book ID
120775759
Publisher
Springer
Year
2013
Tongue
English
Weight
163 KB
Volume
92
Category
Article
ISSN
0939-5555

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Analysis of chromosomal imbalances in de
Analysis of chromosomal imbalances in de novo CD5-positive diffuse large-B-cell lymphoma detected by comparative genomic hybridization
✍ Sivasundaram Karnan; Hiroyuki Tagawa; Ritsuro Suzuki; Miyuki Suguro; Motoko Yama 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 107 KB

We recently demonstrated that the prognosis for de novo CD5-positive (CD5+) diffuse large-B-cell lymphoma (DLBCL) is markedly worse than that for CD5-negative (CD5-) DLBCL. Our findings also suggested that on the basis of its clinical features CD5+ DLBCL may constitute a unique disease category. How

The therapeutic effect of rituximab on C
The therapeutic effect of rituximab on CD5-positive and CD5-negative diffuse large B-cell lymphoma
✍ Rie Hyo; Naoto Tomita; Kengo Takeuchi; Tomohiro Aoshima; Atsuko Fujita; Hideyuki 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 111 KB

## Abstract The prognosis of diffuse large B‐cell lymphoma (DLBCL) has improved markedly in recent years of rituximab era. The prognosis of __de novo__ CD5‐positive DLBCL is reported to be poor, but the effect of rituximab on this type of lymphoma remains unclear. To investigate the effect of ritux